Skip to main content

Post-Market Surveillance Study to Evaluate the Long-Term Safety and Effectiveness of the LVIS Device

Enrolling by invitation · NCT05453240

Conditions: Intracranial Aneurysms

At a glance

Research payments reported, 2025
$447,702
U.S. investigators named
18
Sites paid
17
Planned or actual enrollment
250

About the trial

Sponsor
Microvention-Terumo, Inc.
Dates
Started 2020-11-17; completion 2026-01-01
Results posted
Not yet

The proposed study is a multi-center single arm retrospective and prospective data collection, of patients treated with the LVIS device of specific sizes of 3.5mm, 4.0mm, 4.5mm, 5.5mm with up to 5 years follow-up. Information collected during the study will be standardized across centers to include pre-treatment baseline characteristics of patients including aneurysm(s) symptoms, procedural information, prespecified clinical safety events of interest, and follow-up imaging, clinical visits or telephone calls.

From ClinicalTrials.gov, last updated 2025-06-17. Full record, eligibility and contacts (opens in a new tab)

Industry funding

Microvention, Inc. reported $447,702 in research payments for this study in 2025 (34 payments).

Products named: Stent, Lvis

Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.

U.S. investigators named on this study

Clinicians the company named as principal investigators in its Open Payments reports.

Sites paid to run it

Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.